open access

Vol 86, No 6 (2018)
REVIEWS
Published online: 2018-12-30
Submitted: 2018-11-12
Accepted: 2018-12-17
Get Citation

Epicardial fat in patients with chronic obstructive pulmonary disease as a marker of high cardiovascular risk — review

Milan Sova, Samuel Genzor, Vítězslav Kolek, Filip Čtvrtlík, Amjad Ghazal Asswad, Ondřej Zela, Zdeněk Tauber
DOI: 10.5603/ARM.a2018.0051
·
Pubmed: 30595000
·
Adv Respir Med 2018;86(6):314-318.

open access

Vol 86, No 6 (2018)
REVIEWS
Published online: 2018-12-30
Submitted: 2018-11-12
Accepted: 2018-12-17

Abstract

Chronic obstructive pulmonary disease (COPD) and cardiovascular diseases (CVD) are commonly interconnected, and this coincidence negatively influences patients’ mortality and morbidity. On the basis of the current available data originating mainly from cardiovascular studies epicardial fat (EF) has been proposed as a marker of cardiovascular risk. This review is focused on a potential role of epicardial fat as a new biomarker for risk stratification of COPD patients. Epicardial fat may present an important link between chronic obstructive pulmonary disease and cardiovascular diseases, mainly coronary artery disease.

Abstract

Chronic obstructive pulmonary disease (COPD) and cardiovascular diseases (CVD) are commonly interconnected, and this coincidence negatively influences patients’ mortality and morbidity. On the basis of the current available data originating mainly from cardiovascular studies epicardial fat (EF) has been proposed as a marker of cardiovascular risk. This review is focused on a potential role of epicardial fat as a new biomarker for risk stratification of COPD patients. Epicardial fat may present an important link between chronic obstructive pulmonary disease and cardiovascular diseases, mainly coronary artery disease.

Get Citation

Keywords

epicardial fat, COPD, risk stratification

About this article
Title

Epicardial fat in patients with chronic obstructive pulmonary disease as a marker of high cardiovascular risk — review

Journal

Advances in Respiratory Medicine

Issue

Vol 86, No 6 (2018)

Pages

314-318

Published online

2018-12-30

DOI

10.5603/ARM.a2018.0051

Pubmed

30595000

Bibliographic record

Adv Respir Med 2018;86(6):314-318.

Keywords

epicardial fat
COPD
risk stratification

Authors

Milan Sova
Samuel Genzor
Vítězslav Kolek
Filip Čtvrtlík
Amjad Ghazal Asswad
Ondřej Zela
Zdeněk Tauber

References (29)
  1. Zagaceta J, Zulueta JJ, Bastarrika G, et al. Epicardial adipose tissue in patients with chronic obstructive pulmonary disease. PLoS One. 2013; 8(6): e65593.
  2. Rosito GA, Massaro JM, Hoffmann U, et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation. 2008; 117(5): 605–613.
  3. Wong CX, Ganesan AN, Selvanayagam JB. Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions. Eur Heart J. 2017; 38(17): 1294–1302.
  4. Thanassoulis G, Massaro JM, O'Donnell CJ, et al. Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study. Circ Arrhythm Electrophysiol. 2010; 3(4): 345–350.
  5. Salazar J, Luzardo E, Mejías JC, et al. Epicardial fat: physiological, pathological, and therapeutic implications. Cardiol Res Pract. 2016; 2016: 1291537.
  6. Çetin M, Kocaman S, Durakoğlugil M, et al. Effect of epicardial adipose tissue on diastolic functions and left atrial dimension in untreated hypertensive patients with normal systolic function. Journal of Cardiology. 2013; 61(5): 359–364.
  7. Mahajan R, Kuklik P, Grover S, et al. Cardiovascular magnetic resonance of total and atrial pericardial adipose tissue: a validation study and development of a 3 dimensional pericardial adipose tissue model. J Cardiovasc Magn Reson. 2013; 15: 73.
  8. Nelson AJ, Worthley MI, Psaltis PJ, et al. Validation of cardiovascular magnetic resonance assessment of pericardial adipose tissue volume. J Cardiovasc Magn Reson. 2009; 11: 15.
  9. Thanassoulis G, Massaro JM, O'Donnell CJ, et al. Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study. Circ Arrhythm Electrophysiol. 2010; 3(4): 345–350.
  10. Mahabadi AA, Lehmann N, Kälsch H, et al. Association of epicardial adipose tissue and left atrial size on non-contrast CT with atrial fibrillation: the Heinz Nixdorf Recall Study. Eur Heart J Cardiovasc Imaging. 2014; 15(8): 863–869.
  11. Bertaso AG, Bertol D, Duncan BB, et al. Epicardial fat: definition, measurements and systematic review of main outcomes. Arq Bras Cardiol. 2013; 101(1): e18–e28.
  12. Kaplan O, Kurtoglu E, Gozubuyuk G, et al. Epicardial adipose tissue thickness in patients with chronic obstructive pulmonary disease having right ventricular systolic dysfunction. Eur Rev Med Pharmacol Sci. 2015; 19(13): 2461–2467.
  13. Iacobellis G, Willens HJ. Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr. 2009; 22(12): 1311–9; quiz 1417.
  14. Iacobellis G, Ribaudo MC, Assael F, et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab. 2003; 88(11): 5163–5168.
  15. Thanassoulis G, Massaro JM, O'Donnell CJ, et al. Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study. Circ Arrhythm Electrophysiol. 2010; 3(4): 345–350.
  16. Yudkin JS, Eringa E, Stehouwer CDA. "Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet. 2005; 365(9473): 1817–1820.
  17. Iacobellis G. Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol. 2015; 11(6): 363–371.
  18. Schäffler A, Schölmerich J. Innate immunity and adipose tissue biology. Trends Immunol. 2010; 31(6): 228–235.
  19. Friedman JM. Obesity in the new millennium. Nature. 2000; 404(6778): 632–634.
  20. Greulich S, Chen W, Maxhera B. Cardioprotective properties of omentin-1 in type 2 diabetes: evidence from clinical and in vitro studies. PLoS ONE. 2013; 8(3): e59697.
  21. Sanchez F, Garcıa R, Alarcon F. Adipocinas, tejido adiposo y su relaci´on con c´elulas del sistema inmune. Gaceta Medica de Mexico. 2005; 141(6): 505–512.
  22. Matsuda M, Shimomura I. Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesityassociated insulin resistance and cardiovascular risk. Hormone molecular biology and clinical investigation. 2014; 19(2): 75–88.
  23. Bastard JP, Maachi M, Lagathu C. Recent advances in the relationship between obesity, inflammation, and insulin resistance. European Cytokine Network. 2006; 17(1): 4–12.
  24. Ichiki Y, Kitamura K, Kangawa K. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Letters. 1994; 338(1): 6–10.
  25. Lima M, Torres C, Rosa F. Adrenomedulina: żm´as que una simple hormona? Revista Venezolana de Endocrinolog´ıa y Metabolismo. 2011; 1: 4–11.
  26. Kang YS. Obesity associated hypertension: new insights into mechanism. Electrolyte and Blood Pressure. 2013; 11(2): 46.
  27. Baker AR, Harte AL, Howell N, et al. Epicardial adipose Tissue as a Source of Nuclear Factor-κB and c-Jun N-Terminal Kinase Mediated Inflammation in Patients with Coronary Artery Disease. The Journal of Clinical Endocrinology & Metabolism. 2009; 94(1): 261–267.
  28. Klouche M, Bhagdi S, Hemmes M. Rose-John, Novel path to activation of vascular smooth muscle cells: upregulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor. The Journal of Immunology. 1999; 163(8): 4583–4589.
  29. Sanchez FS, Garcia S, Alarcon F, et al. Adipocinas, tejido adiposo y su relaci´on con c´elulas del sistema inmune. Gaceta Medica de Mexico. 2005; 141(6): 505–512.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl